Code: ES-CA-FO-019

Version: 01

ANALYSIS REPORT Date of issue: 21 december 2022

Oscar Mauricio Franco Ulloa

Cel: 315 80 55 342
1. ORGANOLEPTIC PROPERTIES ANALYSIS REPORT
22038-NP-CO-FS
Sample identification: Crude Cannabis Extract Batch: - 25,9 Kg –
Type of sample: Crude Oil Cannabis type: Non Psychoactive

Figure 1. Aspect of the Crude Cannabis Extract.

PROPERTY RESULT
Product made from the extraction of flowering tops of Cannabis sativa plants supplied to
General information
the laboratory.
Appearance Black viscous crude oil.
Foreign matter Free from any visually foreing matter
2. CANNABINOID ANALYSIS REPORT

Date received: 04/04/2023 Date of analysis: 04/04/2023

Applicant company Dharma Pharma
Analysis: Determination of phytocannabinoids by high performance liquid chromatography

CHROMATOGRAPHIC SYSTEM:

1. Chromatographic equipment: Sample analysis was performed on a liquid chromatograph 1260 infinity II Quaternary
system (Agilent Technologies), with variable wave detector. Injection was performed with a volume of 5 μL.
2. Column: Agilent InfinityLab Poroshell 120 EC-C18, 3.0 × 50 mm, 2.7 µm, capable of heating to a temperature of 50°C.
3.Analysis: the sample was analyzed in duplicate, passing first a mobile phase blank.

Pag 1 de 3
The contents of this document are the property and exclusive use of Dharma Pharma SAS
RESULTS:
Table 1. Major CBN´S Concentration of cannabinoids.

Analyte Concentration (%) Ref. method

CBD 53,1 Cannabinoid potency

CBN 0,07 Cannabinoid potency

Delta9-THC 0,80 Cannabinoid potency

CBC 1,05 Cannabinoid potency

Total CBN’S
%CBDtot: 53,1 %THCtot: 0,80

Figure 1. Chromatogram of Crude Cannabis Extract.

SPACE FOR SAMPLE CHROMATOGRAM / ESPACIO PARA CROMATOGRAMA DE LA

MUESTRA

Figure 2. Chromatogram of the reference sample.

Made by: Diana Uribe Reviewed by: Juan Felipe

Quality Control Analyst RuedaHead of Quality Control

Página 2 de 3
The contents of this document are the property and exclusive use of Dharma Pharma S.A.S